Evidence‑Based Management of Binge Eating Disorder

First‑Line Psychotherapy

• The American Psychiatric Association gives a strong recommendation (Level 1C) that eating‑disorder‑focused psychotherapy should be the initial treatment for binge‑eating disorder, delivered as either individual or group therapy. 1
• Cognitive‑behavioral therapy (CBT) is the most robustly supported psychotherapy, showing large effect sizes for reducing binge‑eating episodes and related psychopathology; the evidence is moderate quality. 1
• Interpersonal therapy (IPT) is an equally valid first‑line option that targets interpersonal relationships and emotional triggers; it has low‑quality evidence but remains recommended as an alternative. 2
• Both individual and group delivery formats are effective, allowing flexibility based on patient preference and resource availability. 2

Pharmacotherapy (Second‑Line)

• If the patient prefers medication or demonstrates minimal or no response to psychotherapy after 6 weeks, a pharmacologic agent should be added. 3

• Lisdexamfetamine

  • Holds the strongest pharmacologic evidence for binge‑eating disorder (low‑quality support).
  • Reduces binge‑eating frequency (Risk Ratio = 2.61; 95 % CI 2.04–3.33).
  • Produces modest weight loss (Mean Difference ≈ ‑5 kg).
  • Decreases binge‑related obsessions/compulsions (Mean Difference ≈ ‑6.5).
  • Common adverse effects include headache, gastrointestinal upset, sleep disturbance, sympathetic arousal (RR 1.63–4.28 vs. placebo), and dry mouth. 1

• Antidepressants (SSRIs or SGAs)

  • Offer modest benefit with low‑quality evidence.
  • Increase binge‑eating abstinence (RR = 1.67; 95 % CI 1.24–2.26).
  • Reduce binge‑related obsessions/compulsions (MD ≈ ‑3.8) and depressive symptoms (MD ≈ ‑2.0).
  • Do not produce significant weight loss. 2

• Medication selection hierarchy (per APA guidance):

Treatment Algorithm

• Step 1 – Initiate psychotherapy (CBT or IPT, individual or group). 1
• Step 2 – Evaluate response at 6 weeks:
  
  • Good response → continue psychotherapy alone. 2
  • Minimal/no response or patient preference for medication → add pharmacotherapy. 2
• Step 3 – Choose pharmacologic agent according to the hierarchy above. 5
• Step 4 – Consider combination therapy only for treatment‑refractory cases, as adding medication does not consistently improve outcomes beyond single‑modality treatment.

Initial Assessment & Multidisciplinary Care

• Baseline assessment should document:

  • Binge‑eating frequency, intensity, and patterns. 6
  • Weight history and current body‑mass index. 6
  • Co‑occurring psychiatric conditions (e.g., depression, anxiety). 5
  • Comprehensive metabolic panel, complete blood count, liver and renal function tests. 1
  • Vital signs, including orthostatic measurements. 5
  • Prior treatment responses. 5

• Multidisciplinary approach: treatment plans must integrate medical, psychiatric, psychological, and nutritional expertise, ideally through a coordinated care team. 7